Hepatocyte Growth Factor Market

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
Hepatocyte Growth Factor Market aims to provide a comprehensive presentation of the global market for Hepatocyte Growth Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatocyte Growth Factor. Hepatocyte Growth Factor Market contains market size and forecasts of Hepatocyte Growth Factor in global, including the following market information:
Global Hepatocyte Growth Factor Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hepatocyte Growth Factor Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hepatocyte Growth Factor companies in 2022 (%)
The global Hepatocyte Growth Factor market was valued at US$ 46 million in 2022 and is projected to reach US$ 271 million by 2029, at a CAGR of 28.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Asia Pacific will be the largest region of Hepatocyte Growth Factor, which will occupy about 60% market share in 2030. North America will be the second largest market with the consumption market share of 25% in 2030. ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners and Yooyoung Pharm are the major manufacturers of industry.
We surveyed the Hepatocyte Growth Factor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatocyte Growth Factor Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatocyte Growth Factor Market Segment Percentages, by Type, 2022 (%)
Phase III (Ongoing)
Phase II (Approved)
Phase II (Ongoing)
Phase 1
Preclinical
Global Hepatocyte Growth Factor Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatocyte Growth Factor Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiovascular
Central Nervous System
Hematological Disorders
Others
Global Hepatocyte Growth Factor Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatocyte Growth Factor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatocyte Growth Factor revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatocyte Growth Factor revenues share in global market, 2022 (%)
Key companies Hepatocyte Growth Factor sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hepatocyte Growth Factor sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViroMed
AnGes MG
M3 Biotechnology
AVEO Pharmaceuticals
Molecular Partners
Yooyoung Pharm
F-star
Galaxy Biotech
Kringle Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatocyte Growth Factor, market overview.
Chapter 2: Global Hepatocyte Growth Factor market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatocyte Growth Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatocyte Growth Factor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatocyte Growth Factor capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.